Relapse Kala-azar: A potential threat to sustaining public health elimination in Bangladesh and ways to overcome it

Authors

  • Shrebash Paul Junior consultant, Medicine, Infectious Disease Hospital, Mohakhali, Dhaka-1212
  • Ariful Basher Senior consultant (Medicine) and superintendent, Infectious Disease Hospital, Mohakhali, Dhaka-1212
  • Kazi Ali Aftab Assistant Professor, Department of Internal Medicine, Bangladesh Medical University, Dhaka-1000
  • Khaled Mahbub Murshed Assistant Professor, Department of Internal Medicine, Bangladesh Medical University, Dhaka-1000
  • Md Abdul Kader Professor, Department of Internal Medicine, Bangladesh Medical University, Dhaka-1000
  • Fazle Rabbi Chowdhury Associate Professor, Department of Internal Medicine, Bangladesh Medical University, Dhaka, Bangladesh, and Research Fellow, Queens Medical Research Institute, University of Edinburgh, UK, EH4 6EH

DOI:

https://doi.org/10.3329/jom.v26i2.84360

Keywords:

Relapse Kala-azar, Bangladesh, Refractory Kala-azar

Abstract

Leishmaniasis is a cluster of zoonotic diseases caused by more than 20 species of Leishmania parasites. It manifests in three primary clinical forms: visceral, cutaneous, and mucocutaneous leishmaniasis. Visceral leishmaniasis is the gravest form, which is endemic in Bangladesh. Bangladesh experiences the highest number of cases between 1993 and 2005, affecting 45 districts across the country. Over the years, Bangladesh has successfully reduced its burden through the effective implementation of the National Kala-azar Elimination Program (NKEP) since 2008, resulting in the country becoming the first in the world to achieve the historic milestone of a public health elimination certificate from the WHO.At this stage, prevention of transmission and eradication of parasites are the cornerstones in sustaining the public health elimination status. Relapse kala-azar (RKA) patients (single and multiple) are the potential threat to achieving this, as RKA patients act as an archive or repository for the L. donovani parasite.This review highlighted the potential risk factors of RKA, challenges associated with RKA, and possible solutions for mitigating outbreaks of RKA. Male gender, younger population, immunocompromised status, shorter regimen of treatment, splenomegaly, cytopenia, malnutrition, and poor socioeconomic status are the common risk factors. Significant challenges to be encountered are asymptomatic carriers, parasitological confirmation, availability of drugs, potential drug resistance, and the appearance of cases (refractory KA, Para-Kala azar dermal leishmaniasis) that are difficult to treat. The increasing availability of molecular diagnosis and xenodiagnosis, longer treatment regimens (multidose, combination, and secondary prophylaxis), the availability of drugs, and the development of new molecules may be possible solutions for the effective management of RKA, which is crucial for sustaining public health elimination of KA in Bangladesh. It is now time to update the clinical case management guideline and revise the dose of LAmB to 15 mg/kg in divided doses.The provision of secondary prophylaxis needs to be added in the guideline for treating RfKA and para-KDL cases.

J MEDICINE 2025; 26(2): 131-141

Downloads

Download data is not yet available.
Abstract
22
PDF
16

Downloads

Published

2025-09-28

How to Cite

Paul, S., Basher, A., Aftab, K. A., Murshed, K. M., Kader, M. A., & Chowdhury, F. R. (2025). Relapse Kala-azar: A potential threat to sustaining public health elimination in Bangladesh and ways to overcome it. Journal of Medicine, 26(2), 131–141. https://doi.org/10.3329/jom.v26i2.84360

Issue

Vol. 26 No. 2 (2025)

Section

Review Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

  1. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).